Amyloid Beta (25 - 35)
Preclinical Study on Expression of Bax and Bcl 2 Apoptotic Regulatory Proteins on Amyloid Beta (Aβ 25 35) Induced Oxidative Stress in Alzheimer’s Mice
... called amyloid beta which is a hallmark protein majorly responsible for triggering most of the inflammatory episodes in the etiology of the ...in amyloid induced neurodegenrated mice ...in ...
7
Anti-Amnesic Effects of Evolvulus Alsinoides Linn. in Amyloid beta (25-35) Induced Neurodegeneration in Mice.
... stress signaling is speculated in the pathology of AD and other neurodegenerative disorders 9 . The free radical produced during oxidative stress causes the DNA and RNA oxidation indicated by increased levels of ...
11
NOOTROPIC ACTIVITY OF ISORHAMNETIN IN AMYLOID BETA 25 35 INDUCED COGNITIVE DYSFUNCTION AND ITS RELATED mRNA EXPRESSIONS IN ALZHEIMER’S DISEASE
... tangles 25-26 and the toxicity induced by Aβ (25–35) in rodents resembles to AD which is suitable for the evaluation of Alzheimer’s type of ...
10
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
... Figure 6 TeM analysis of AuNP–Aβ42 incubated with blood-derived serum from normal and AD patients. sera from normal individuals (n = 4) and AD patients (n = 4) were incubated with AuNP–Aβ42 during aggregation. AuNP–Aβ42 ...
12
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
... : amyloid beta-peptide; AD: Alzheimer ’ s disease; APP: amyloid precursor protein; APPsw: Swedish familial Alzheimer ’ s disease mutant isoform of APP: BACE: beta-APP cleaving enzyme; ...
21
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
... the amyloid beta (A β ) pla- ques, the dominant hypothesis regarding AD (the ‘amyloid cascade hypothesis ’ ) is that this 39- to 43-amino acid A β peptide is the neurotoxic cause of brain dysfunction ...
9
The biochemical aftermath of anti-amyloid immunotherapy
... APP: amyloid-beta precursor protein; BBB: blood brain barrier; BSHRI: Banner Sun Health Research Institute; CAA: cerebral amyloid angiopathy; CERAD: Consortium to Establish a Registry for Alzheimer ’ ...
15
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report
... Results: This review identifies a large number of biochemical markers derived from CSF and blood. There is a considerable overlap of VCI-SSVD clinical symptoms with those of Alzheimer ’ s disease (AD). Although most of ...
12
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
... how amyloid beta or its soluble oligomers interact with mitochondria through multiple ...loid beta occurs in the brain mitochondria, with diminished activities of respiratory chain enzymes and ...
14
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
... : Amyloid beta; A β 40: 40-aminoacid isoform of amyloid beta; A β 42: 42-aminoacid isoform of amyloid beta; BLAD: Bateria de Lisboa para Avaliação de Demência (Lisbon Battery for ...
15
The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
... : Amyloid-beta; A β PP: Amyloid-beta precursor protein; BSA: Bovine serum albumin; CPRG: Chlorophenol-red β -D-galactopyranoside; CSF: Cerebrospinal fluid; DAP12: DNAX activating protein of 12 ...
13
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
... with Amyloid-beta (A β ) protein aggregation, which results in extracellular plaques in the brain, and according to the amyloid cascade hypothesis appeared to be a promising target for the ...
9
Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease
... AC. Amyloid beta peptide 1–42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical ...
5
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
... the amyloid cascade hypothesis (ACH). Circulating anti-amyloid- beta (A β ) antibodies are expected to prevent de novo A β development and reduce existing deposits of harmful A β in the ...
8
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
... peptide amyloid beta (Aβ), bapineuzu- mab and solanezumab, have failed to improve clinical out- comes in patients with late onset AD ...long-standing amyloid hypothesis, and are the latest ex- amples ...
5
Microglial pathology
... the amyloid cascade/neuroinflammation hy- pothesis, deposits of amyloid-beta (Aβ) protein incite chronic microglial activation and with it a detrimental neuroinflammatory reaction characterized by ...
17
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
... : Amyloid-beta; A β PP swe : Amyloid-beta precursor protein, human Swedish mutation; AD: Alzheimer ’ s disease; C3B6: Mice with a combination C3H/He and C57BL/6 background; CAT: Catalase; ...
21
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
... to many neurodegenerative disorders. Aging is associated with gliosis, increased microglial activity [5] and astrocyto- sis in the brain [34]. In healthy controls we found a positive correlation between age and sTREM2 ...
11
Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss
... It has been reported that CX3CR1 and CCR2 play a role in the pathogenesis of AD in some mouse models of the disease, either by affecting microglia or by limiting the infiltration of monocytes [49–51]. In the Arctic model ...
19
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
... Th e principal neuropathological changes in ADAD – neuronal loss, neurofi brillary tangles, senile plaques, and cerebral amyloid angiopathy (CAA) – mirror those seen in SAD, providing strong support for ADAD as a ...
13